Position in DFTX
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$4,167,649
New position
Shares Held
88,598
first reported quarter
Ownership
0.066%
of shares outstanding
% of Portfolio
0.55%
of 13F equity value
Holder Rank
#105
of 355 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 64%
Shared 0%
None 36%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Pier Capital, LLC holds $37,295,784 across 8 Biotechnology names. DFTX ranks #4 (11.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DRTS |
Alpha Tau Medical Ltd.
|
691,939 | $8,704,592 | |
| 2 | COGT |
Cogent Biosciences, Inc.
|
188,951 | $7,312,403 | |
| 3 | CYTK |
Cytokinetics Inc
|
70,665 | $6,019,951 | |
| 4 | DFTX |
Definium Therapeutics, Inc.
This page
|
88,598 | $4,167,649 | |
| 5 | SPTX |
Seaport Therapeutics, Inc.
|
169,985 | $3,692,074 | |
| 6 | OLMA |
Olema Pharmaceuticals, Inc.
|
220,699 | $2,760,944 | |
| 7 | CAPR |
Capricor Therapeutics, Inc.
|
111,908 | $2,694,744 | |
| 8 | KYMR |
Kymera Therapeutics, Inc.
|
16,948 | $1,943,427 |
All Filings in DFTX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,167,649 | 88,598 | Shares | Sole | 2026-08-05 | |
| No filing history on record for this holder in this stock. | ||||||